raloxifene hydrochloride has been researched along with Urogenital Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jian, W; Lerner, SP; Okuno, N; Shen, SS; Smith, CL; Sonpavde, G; Weiss, H; Younes, M; Yu, J | 1 |
1 other study(ies) available for raloxifene hydrochloride and Urogenital Neoplasms
| Article | Year |
|---|---|
Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.
Topics: Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Transplantation, Heterologous; Treatment Outcome; Urogenital Neoplasms | 2007 |